Patients Coming Off Slimming Injections Gain Back Weight at a Quadrupled Rate Than People Using Diet and Exercise

A recent study reveals that people who discontinue popular weight-loss injections like Mounjaro or Wegovy can put back on lost weight much more quickly than those who stop conventional lifestyle programs.

Findings released in a leading health publication points out that while overweight people can lose substantial amounts of their body weight while undergoing treatment, the weight returns at an estimated rate of 0.8 kg per month once they quit.

"Users purchasing these drugs should be aware of the risk of quick rebound weight gain when the therapy ends," stated lead investigator Dr. Susan Jebb.

That rate of regain suggests a return to starting weight in about one and a half years.

Analyzing Therapies

The study, which looked at 37 of trials involving thousands of patients, contrasted the outcomes of the injectable medications with other pills.

Scientists note that individuals who lose weight through dieting typically see a less rapid creep back—perhaps 0.1 kg a month—once they finish.

Explaining the Fast Rebound

Experts propose the mode of action of the injections accounts for the amplified weight return.

These medications imitate a natural hormone called GLP-1, which moderates appetite.

"Sustained high doses of the hormone levels several times higher than the body's typical production might result in the body to produce less of its own natural GLP-1, and could lessen sensitivity to its actions," said Dr. Adam Collins, a nutrition researcher.

"Stopping of this medication leads to appetite is no longer kept in check, making binge eating far more likely."

An Ongoing Disease?

Medical guidelines advise the jabs for individuals with weight-linked health risks, accompanied by recommended lifestyle changes.

Many experts contend that, due to the likelihood of weight regain, the treatment should be considered life-long.

This opinion is echoed by pharmaceutical companies, who state that the findings "emphasize the chronic character of obesity," similar to managing diseases like high blood pressure.

User Experiences

Users who have come off the jabs describe a sudden resurgence of hunger.

"It was like a switch activating and I was suddenly extremely hungry," said an individual.

The struggle is compounded if individuals have not established sustainable dietary or behavioural modifications during treatment.

Growing Adoption

Recent estimates show that millions of adults in the UK have tried these injections in the past year, with desire remaining high.

• Adoption is higher among women than men.
• The 40s and 50s demographic shows the greatest level of interest.
• Many access the drugs through private prescriptions rather than public health services.

In conclusion, researchers stress that while these medications are effective agents for shedding pounds, they are not a magic fix and lasting health benefits hinges on ongoing behavioural support.